These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1012 related articles for article (PubMed ID: 18182619)
1. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619 [TBL] [Abstract][Full Text] [Related]
2. Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer. Ochiumi T; Kitadai Y; Tanaka S; Akagi M; Yoshihara M; Chayama K Int J Oncol; 2006 Jul; 29(1):105-16. PubMed ID: 16773190 [TBL] [Abstract][Full Text] [Related]
3. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303 [TBL] [Abstract][Full Text] [Related]
4. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach. Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451 [TBL] [Abstract][Full Text] [Related]
5. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Kawakami T; Tokunaga T; Hatanaka H; Kijima H; Yamazaki H; Abe Y; Osamura Y; Inoue H; Ueyama Y; Nakamura M Cancer; 2002 Nov; 95(10):2196-201. PubMed ID: 12412174 [TBL] [Abstract][Full Text] [Related]
6. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference. Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596 [TBL] [Abstract][Full Text] [Related]
7. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR]. Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933 [TBL] [Abstract][Full Text] [Related]
8. Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF. Kim WH; Lee SH; Jung MH; Seo JH; Kim J; Kim MA; Lee YM Exp Cell Res; 2009 Aug; 315(13):2154-64. PubMed ID: 19409892 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma. Raskopf E; Vogt A; Standop J; Sauerbruch T; Schmitz V Z Gastroenterol; 2010 Jan; 48(1):21-7. PubMed ID: 20072992 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358 [TBL] [Abstract][Full Text] [Related]
11. Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development. Young N; Hahn CN; Poh A; Dong C; Wilhelm D; Olsson J; Muscat GE; Parsons P; Gamble JR; Koopman P J Natl Cancer Inst; 2006 Aug; 98(15):1060-7. PubMed ID: 16882943 [TBL] [Abstract][Full Text] [Related]
14. Interference with netrin-1 and tumor cell death in non-small cell lung cancer. Delloye-Bourgeois C; Brambilla E; Coissieux MM; Guenebeaud C; Pedeux R; Firlej V; Cabon F; Brambilla C; Mehlen P; Bernet A J Natl Cancer Inst; 2009 Feb; 101(4):237-47. PubMed ID: 19211441 [TBL] [Abstract][Full Text] [Related]
15. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707 [TBL] [Abstract][Full Text] [Related]
16. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057 [TBL] [Abstract][Full Text] [Related]
17. Expression of Neuropilin-2 in salivary adenoid cystic carcinoma: its implication in tumor progression and angiogenesis. Cai Y; Wang R; Zhao YF; Jia J; Sun ZJ; Chen XM Pathol Res Pract; 2010 Dec; 206(12):793-9. PubMed ID: 20851535 [TBL] [Abstract][Full Text] [Related]
18. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo. Moore LD; Isayeva T; Siegal GP; Ponnazhagan S Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771 [TBL] [Abstract][Full Text] [Related]
19. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells. Zhang J; Ren H; Yuan P; Lang W; Zhang L; Mao L Cancer Res; 2006 Jan; 66(1):18-23. PubMed ID: 16397209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]